1Lun·

Intuitive Surgical Q1'25 Earnings Highlights

$ISRG (-0,26 %)


🔹 Adj. EPS: $1.81 (Est: $1.72) 🟢; ▲ +21% YoY

🔹 Revenue: $2.25B (Est: $2.19B) 🟢; ▲ +19% YoY


🔸 FY25 margin guidance reflects 1.7% revenue impact from current tariffs. Additional tariffs may materially impact financials further.


Segment Performance

🔹 Instruments & Accessories Revenue: $1.37B (Est: $1.34B) 🟢; ▲ +18% YoY

🔹 Systems Revenue: $523M; ▲ +25% YoY

🔹 Services Revenue: $356M; ▲ +13% YoY


Operating Metrics

🔹 da Vinci Procedures Growth: ▲ +17% YoY

🔹 Systems Placed: 367 units (vs. 313 YoY)

  • 147 da Vinci 5 systems (vs. 8 YoY)

🔹 Installed Base: 10,189 systems (▲ +15% YoY)

🔹 Operating Cash Flow: $— (Cash up $269M in Q1)

🔹 Ending Cash & Investments: $9.10B


FY25 Guidance

🔹 Worldwide Procedure Growth: 15%–17%

🔹 Gross Margin (non-GAAP): 65%–66.5% (vs. 69.1% FY24)

🔹 Operating Expense Growth (non-GAAP): 10%–14%

🔸 Tariff headwind: ~170 bps impact to margins expected


CEO Commentary

🔸 “Core measures of our business were healthy this quarter, and we are pleased by continued customer adoption of our platforms, including da Vinci 5.” – Gary Guthart, CEO

9
Únase a la conversación